Increasing survival in soft tissue sarcoma patients with lung metastases undergoing resection
Monday, May 16, 2016 - 20:00
in Health & Medicine
Up to 50% of patients with soft tissue sarcoma (STS) develop lung metastases. Effective systemic therapies for metastatic STS are currently limited; when possible, surgical removal of the lung metastases (known as pulmonary metastasectomy, PM) is the preferred treatment. However, guidelines for the performance of PM for STS do not exist and decisions to operate are often made on an individual basis.